Machina Capital’s Royalty Pharma RPRX Stock Holding History

Machina Capital’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Buy	+30,050	New	+$1.56M	0.27%	126
2026 Q1	–	Sell	-18,017	Closed	-$696K	–	444
2025 Q4	$696K	Buy	18,017 +11,296	+168%	+$431K	0.13%	213
2025 Q3	$237K	Buy	+6,721	New	+$243K	0.04%	300
2025 Q2	–	Sell	-12,019	Closed	-$374K	–	387
2025 Q1	$374K	Sell	12,019 -3,978	-25%	-$126K	0.11%	228
2024 Q4	$408K	Sell	15,997 -12,740	-44%	-$338K	0.17%	184
2024 Q3	$813K	Buy	28,737 +5,891	+26%	+$163K	0.32%	120
2024 Q2	$602K	Buy	22,846 +14,651	+179%	+$406K	0.27%	137
2024 Q1	$249K	Sell	8,195 -16,331	-67%	-$481K	0.13%	224
2023 Q4	$689K	Buy	+24,526	New	+$674K	0.44%	85
2023 Q3	–	Sell	-11,011	Closed	-$338K	–	349
2023 Q2	$338K	Buy	11,011 +1,013	+10%	+$34.3K	0.19%	191
2023 Q1	$360K	Buy	+9,998	New	+$371K	0.32%	120

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Machina Capital's RPRX Position: Q2 2026 in Review

Machina Capital opened a new position in Royalty Pharma (RPRX) in Q2 2026: 30,050 shares worth $1.68M. The stake represents 0.27% of the portfolio and ranks #126 among its holdings. This is a return to the name: Machina Capital previously reported a position in RPRX as recently as Q4 2025.

Machina Capital first reported a position in RPRX in Q1 2023 and has held it in 11 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Machina Capital held 30,050 shares of Royalty Pharma worth $1.68M as of Q2 2026.
Royalty Pharma was a new Machina Capital position in Q2 2026.
Royalty Pharma made up 0.27% of Machina Capital's portfolio in Q2 2026, its #126 holding.
Machina Capital first reported a position in Royalty Pharma in Q1 2023 and has held it in 11 quarters since.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.